INHIBITION OF ENDOSOME FUSION BY PHOSPHOLIPASE-A(2) (PLA2) INHIBITORS POINTS TO A ROLE FOR PLA2 IN ENDOCYTOSIS

被引:106
|
作者
MAYORGA, LS
COLOMBO, MI
LENNARTZ, M
BROWN, EJ
RAHMAN, KH
WEISS, R
LENNON, PJ
STAHL, PD
机构
[1] WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110
[2] NATL UNIV CUYO,CONSEJO NACL INVEST CIENTIF & TECN ARGENTINA,INST HISTOL & EMBRIOL,RA-5500 MENDOZA,ARGENTINA
[3] MONSANTO CO,ST LOUIS,MO 63167
关键词
D O I
10.1073/pnas.90.21.10255
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fusion of intracellular membrane-bound compartments is a common step in the transport of macromolecules along the endocytic and secretory pathways. A large number of factors active in the fusion process or its regulation have been identified; however, the actual sequence of events leading to membrane fusion is still unknown. In this study, we have assessed a possible role for PLA2 in endosome fusion by using an in vitro reconstitution assay and by examining endocytosis in intact cells. Several PLA2 inhibitors blocked endosome fusion in a broken-cell preparation. Inhibition was reversed by addition of arachidonic acid. At the electron microscope level, endosome clusters were observed even in the presence of inhibitors; however, actual fusion between endosomes was largely reduced. Fusion frequency increased upon the addition of arachidonic acid. A membrane-permeable PLA2 inhibitor blocked mixing of ligands internalized sequentially but did not affect internalization. The results indicate that vesicle fusion along the endocytic pathway requires a PLA2 activity. The effect of this activity would be, at least in part, mediated by arachidonic acid release.
引用
收藏
页码:10255 / 10259
页数:5
相关论文
共 50 条
  • [1] Phospholipase inhibition:: Medicinal chemistry and therapeutic potential of PLA2 inhibitors
    Rangappa, K. S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (08) : 741 - 742
  • [2] Synthesis of competitive inhibitors of phospholipase A2 (PLA2)
    Mahmoodi, NO
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2002, 177 (12) : 2887 - 2893
  • [3] Role of phospholipase A2(PLA2)-activating protein (PLAP)in modulating PLA2 activity during inflammation
    Chopra, AK
    Ribardo, DA
    Crowe, SE
    Peterson, JW
    GASTROENTEROLOGY, 1999, 116 (04) : A681 - A681
  • [4] Studies on the measurement of phospholipase A2 (PLA2) and PLA2 inhibitor activities in ram semen
    Upreti, GC
    Hall, EL
    Koppens, D
    Oliver, JE
    Vishwanath, R
    ANIMAL REPRODUCTION SCIENCE, 1999, 56 (02) : 107 - 121
  • [5] HUMAN EXTRACELLULAR (TYPE-II) PHOSPHOLIPASE-A(2)(PLA2) TRANSGENIC MICE PROVIDE A MOUSE MODEL FOR EVALUATION OF PLA(2) INHIBITORS
    GRASS, DS
    FELKNER, RH
    CHIANG, MY
    BENNETT, CF
    SWANSON, ME
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S107 - S107
  • [6] PHOSPHOLIPASE-A2 (PLA2) OF THE HERNIATED LUMBAR DISC INHIBITION BY PIROXICAM
    TRON, AM
    MATHIEU, P
    HELLIO, MP
    CONROZIER, T
    PIPERNO, M
    BRET, P
    PERRIN, G
    PESCHARD, MJ
    RICHARD, M
    VIGNON, E
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 592 - 592
  • [7] PHOSPHOLIPASE-A2 (PLA2) ACTIVITY IN RABBIT CHONDROCYTES
    STEVENS, TM
    CHIN, JE
    MCGOWAN, M
    GIANNARAS, J
    KERR, JS
    AGENTS AND ACTIONS, 1989, 27 (3-4): : 385 - 387
  • [8] Structural consequences of covalent inhibition of PLA2
    Tatulian, SA
    BIOPHYSICAL JOURNAL, 2001, 80 (01) : 54A - 54A
  • [9] Reduction by chronic lithium of brain phospholipase A2 (PLA2) activity is not mediated by a decrease in the fractional phosphorylation of cytosolic PLA2
    Weerasinghe, GR
    Seemann, R
    Rapoport, SI
    Bosetti, F
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 499A - 500A
  • [10] Crystal Structure of a Class XIB Phospholipase A2 (PLA2) RICE (ORYZA SATIVA) ISOFORM-2 PLA2 AND AN OCTANOATE COMPLEX
    Guy, Jodie E.
    Stahl, Ulf
    Lindqvist, Ylva
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (29) : 19371 - 19379